Urgent.News

What's breaking now, across hundreds of outlets.

Finance & Markets

Mizoram's traffic etiquette, no honking policy impresses Anand Mahindra: ‘In metros quietness is rare luxury’

Mizoram's capital, Aizawl is recognized as India's ‘silent’ city, following the introduction of the no-honking policy in 2017. A video from of the city's traffic has been shared on X by Anand Mahindra.

Mizoram's traffic etiquette, no honking policy impresses Anand Mahindra: ‘In metros quietness is rare luxury’

Anand Mahindra, Chairman of the Mahindra Group, shared his admiration for the traffic discipline in Aizawl, the capital city of Mizoram. In a video posted on X, Mahindra showcased a silent traffic flow where vehicles remained patient and did not honk, adhering to a no-honking policy introduced by the state government in 2017. A local resident explained how Mizos respect traffic rules and wait patiently within designated lanes, with white lines preventing them from crossing.

The woman praised the patience of the Mizos, urging other Indians across the country to adopt similar traffic etiquette to curb the noise pollution prevalent in big cities. Mahindra highlighted the rarity of quietness in metro cities, where the constant honking has made it a luxury. He concluded by stating that the quest for quietness could be the most compelling reason for people to travel.

Rewritten by urgent.news; may contain errors — check the original.

Source: livemint.com

Read the original at livemint.com →

Report a problem with this story

More in Finance & Markets

Johnson & Johnson vs. Pfizer: Which Healthcare Stock Is a Better Buy for 2027?

Johnson & Johnson's drug-and-device product mix faces off against Pfizer's high-stakes oncology and obesity bets, with a valuation gap that may sway your choice.

  • Johnson & Johnson focuses on drug development and medical devices, with a strong medtech division.
  • Pfizer shifts focus to oncology and weight-loss treatments, investing in Seagen acquisition.
  • J&J offers steady, long-term growth and stability, while Pfizer provides higher dividend yield.

More from Sunday 22 November →